Ven Bio Partners LLC Pharvaris N.V. Transaction History
Ven Bio Partners LLC
- $95 Million
- Q2 2025
A detailed history of Ven Bio Partners LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Ven Bio Partners LLC holds 4,289,304 shares of PHVS stock, worth $92.9 Million. This represents 79.45% of its overall portfolio holdings.
Number of Shares
4,289,304
Previous 4,289,304
-0.0%
Holding current value
$92.9 Million
Previous $67.3 Million
12.1%
% of portfolio
79.45%
Previous 72.08%
Shares
7 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$163 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$95.5 Million85.48% of portfolio
-
Viking Global Investors LP3.65MShares$79.1 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$71.5 Million17.44% of portfolio
-
Vr Adviser, LLC New York, NY2.05MShares$44.3 Million7.14% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $731M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...